West-Atlantic Partners Acquires PrecisionMed, Inc.
January 13, 2021
West-Atlantic Partners has acquired PrecisionMed, Inc. from founders Dr. John Flax and Ronald Flax. The deal will support PrecisionMed’s next phase of growth, enabling expansion of its biorepository and product offerings (notably in neuroscience and oncology research).
- Buyers
- West-Atlantic Partners
- Targets
- PrecisionMed, Inc.
- Sellers
- John Flax, MD, Ronald Flax
- Industry
- Biotechnology
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
McKesson to Acquire Precision Medicine Group, LLC for Approximately $2.25 Billion
August 25, 2026
Healthcare Services
McKesson Corporation signed a definitive agreement to acquire Precision Medicine Group, LLC, a global provider of clinical research and biopharma commercialization services, for approximately $2.25 billion. After completion, Precision Medicine Group will report within McKesson’s Oncology & Multispecialty segment, subject to customary regulatory closing conditions.
-
BioIVT Acquires PrecisionMed
July 18, 2023
Healthcare Services
BioIVT, a global biospecimen solutions provider, has acquired PrecisionMed, LLC, a Carlsbad-based supplier of high-quality human biospecimens and owner of a large longitudinal cerebrospinal fluid (CSF) repository. The acquisition expands BioIVT's supply network, inventory and capacity for CSF and liquid biopsy products while PrecisionMed will continue to operate from its existing headquarters and collection sites.
-
Precision for Medicine Acquires Baseline Controls
June 27, 2023
Healthcare Services
Precision for Medicine has acquired Baseline Controls, a Raleigh-based project controls and project management firm, and will integrate its capabilities into Project Farma to broaden end-to-end biomanufacturing solutions for life science companies. The acquisition expands Precision for Medicine’s technical operations and project planning expertise—targeting faster, more cost-efficient manufacturing for small molecule, biologics and next-generation therapies including cell and gene therapy.
-
Precision Medicine Group Acquires Project Farma
January 14, 2021
Healthcare Services
Precision Medicine Group has acquired Project Farma, a bioengineering services firm specializing in biomanufacturing strategy and facility implementation with a focus on cell and gene therapies. The deal brings Project Farma's manufacturing and scale-up expertise into Precision's cell and gene therapy services (Precision ADVANCE) to expand end-to-end development, manufacturing, and commercialization capabilities.
-
Discovery Life Sciences Acquires East West Biopharma
November 9, 2020
Healthcare Services
Discovery Life Sciences acquired East West Biopharma, a European human biospecimen contract research organization with a large biocollection network in Ukraine. The deal expands Discovery’s biospecimen collection and clinical site footprint across Europe, strengthening its global position as a leading provider of biospecimen and related scientific services.
-
IVX Health Acquires Precision Healthcare
October 14, 2020
Healthcare Services
IVX Health acquired Precision Healthcare, a Nashville-based operator of 12 ambulatory infusion centers in Tennessee and northern Arkansas. The acquisition was financed with preferred equity led by Linden Capital Partners and joined by McKesson Ventures, Health Velocity Capital, and Nueterra Capital; Precision was previously a subsidiary of BAI Healthcare Services (a portfolio company of EW Healthcare Partners).
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.